Le Lézard
Classified in: Health, Science and technology
Subject: Company Name Change

Inocras Inc. Unveils Rebranding of Genome Insight


Inocras, formerly known as Genome Insight, announced today its rebranding initiative to reflect its commitment to innovation and user-centric healthcare solutions.

The AI-driven whole genome platform company, specialized in whole genome sequencing and analytics for cancer and rare diseases, has embarked on its rebranding to reinforce its dedication to shaping an "innovative tomorrow". The rebranding accentuates its focus on "user-centric approaches" for patients, providers, and researchers, surpassing the provision of sequencing and analytics services. This strategic transformation also marks the launch of a redesigned corporate website, symbolizing a fresh chapter in the company's evolution.

"We've paved the way for a future where genomic data is at the core of care by breaking down technology and cost barriers to adopt whole genome approach. Our new identity represents our commitment to unlocking the new era of precision health for everyone with whole genome insights," said Jehee Suh, CEO of Inocras.

Founded in 2020 by a team of physician-scientists, geneticists, and bioinformaticians, the company's goal is to transform patient care by unlocking the vast potential of genomic data. Since then, Inocras developed an IP-protected technology and proprietary whole genome bioinformatics platform while achieving operational excellence in its CLIA certified and CAP accredited lab.

With its new identity, the company is poised to launch its two diagnostic products, CancerVision and RareVision, on a global scale in April 2024. These launches will be accompanied by the introduction of an innovative delivery model: a patient-centric whole genome platform. Additionally, throughout the year, Inocras plans to unveil further whole genome-based diagnostic products, addressing critical care gaps in cancer and rare/neurological disease areas.

"At Inocras, our commitment to advancing patient care and driving groundbreaking research remains unwavering. With our rebranding as Inocras, we reaffirm our dedication to delivering exceptional service to our customers while introducing groundbreaking products that have the potential to revolutionize disease understanding and treatment," added Jehee Suh.

About Inocras Inc:

Inocras Inc. (formerly Genome Insight Inc.) is a pioneering provider of whole genome sequencing and analytics services for cancer and rare diseases. The company is dedicated to unlocking the potential of genomic data to enable precision health for everyone.


These press releases may also interest you

at 14:05
Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases
Progentos Therapeutics, a biotech company addressing the critical unmet need to regenerate myelin and restore function for patients with Multiple Sclerosis (MS) and other demyelinating diseases, today announced its launch and the closing of a $65...

at 14:01
University of Chicago Invites the Public "Inside the Lab"
University labs around the world are catalysts for breakthrough discoveries that improve humanity, but their work can be shrouded in mystery. Inside the Lab, a new video and Q&A series from the University of Chicago, pulls back the curtain for a...

at 13:53
Ribbon-Cutting Ceremony Marks Expansion of Your Six Recovery Program at The Bluffs Addiction Campuses
The Bluffs Addiction Campuses has officially expanded its specialized treatment program, Your Six Recovery (Y6R), dedicated to serving veterans and struggling with addiction and mental health disorders. The ribbon-cutting ceremony on May 13...

at 13:45
AAOS Collaborates with Blue Cross and Blue Shield Association
The American Academy of Orthopaedic Surgeons (AAOS) announced a formal collaboration with Blue Cross and Blue Shield Association (BCBSA) to allow consenting participants' quality outcomes data from the American Joint Replacement Registry (AJRR) to be...

at 13:16
Chris Schaefer Appointed as Chief Financial Officer at CAQH
CAQH is pleased to announce the appointment of Chris Schaefer as the new Chief Financial Officer. Chris will also serve as a member of the Executive Leadership Team. In his new role, Chris will be responsible for directing the organization's...

at 13:15
InventHelp Inventor Develops New Set of Smart Support Bands (BRK-4270)
"I wanted to create a new set of smart support bands to monitor a person's movements and muscle expansion/contraction during exercise workouts, athletic training, or simply everyday activities," said an inventor, from Hueytown, Ala., "so I invented...

More news about Health...


News published on and distributed by: